Roni Wechsler

Dr. Wechsler is Regentis VP R&D. Dr. Wechsler has 20 years of experience in R&D in the Israeli biotechnological and medical device industry in managerial positions. At Regentis he oversees R&D activities, manage scientific collaborations and provides R&D support for company regulatory submissions. In the last 10 years, he has worked in the orthopedic field focusing on development of biomaterials and cell-based technologies for cartilage and bone repair. Dr. Wechsler was involved in other EU funded projects (Bio design, NPMimetic and ADIPOA). He received his B.Sc. in biochemistry from McGill University, Montreal (Canada) and M.Sc. and Ph.D. from The Weizmann Institute of Science (Rehovot, Israel). He also holds a MBA from the Collage of Academic Management, Rishon-Le-Zion (Israel). He is author of 9 peer-reviewed research articles and co-inventor of 3 international patents including the PEG-fibrinogen/Pluronic fibrinogen paste that will be utilized in ADAMIORA.
In the project, he will be the main contact person at Regentis and the scientifically responsible person, leading all technical tasks as well as IP and FTO related tasks through the IPEC.